Beyond the Hairline: Understanding and Treating Androgenetic Alopecia in Men

In this first episode, Joshua Zeichner, MD, shares how to spot early male pattern thinning, why it affects confidence, and which proven treatments beat social media hype.

New hair-loss therapies aim to block DHT at follicles, using targeted scalp delivery to reduce systemic side effects and improve male pattern baldness outcomes.

Joshua Zeichner, MD, presents phase 3 results showing topical clascoterone 5% stays well tolerated for 12 months and boosts hair density, signaling a new DHT-blocking option.

Explore what drives male pattern hair loss, its emotional toll, and why new topical antiandrogen clascoterone may boost density while limiting systemic effects.